Alnylam Pharmaceuticals
ALNY
#378
Rank
โ‚น5.437 T
Marketcap
โ‚น41,156
Share price
-1.55%
Change (1 day)
93.00%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company